Abstract
Purpose
Timely knowledge of the bacterial etiology and localization of infection are important for empirical antibiotic therapy. Thus, the goal of this study was to evaluate routinely used biomarkers together with novel laboratory parameters in the diagnosis of infection.
Methods
In this prospective study, 54 adult patients with bacterial infections admitted to the Department of Infectious Diseases were included. For comparison, 27 patients with viral infections were enrolled. In these patients, white blood cell (WBC) counts, differential blood counts, serum levels of procalcitonin (PCT), IL-1β, IL-6, IL-8, IL-10, IL-12, TNF-α, IFN-γ, soluble CD14 (sCD14), heparin-binding protein (HBP), cortisol (Cort), and monocyte surface expression of TLR2, TLR4, HLA-DR, and CD14 were analyzed. Also, these biomarkers were evaluated in 21 patients with acute community-acquired bacterial pneumonia (CABP), as well as in 21 patients with pyelonephritis and urosepsis.
Results
The highest sensitivity and specificity (expressed as the area under the curve [AUC]) for bacterial infection were observed in serum concentration of PCT (0.952), neutrophil and lymphocyte counts (0.852 and 0.841, respectively), and serum levels of HBP (0.837), IL-6 (0.830), and Cort (0.817). In addition, the serum levels of IFN-γ and Cort were significantly higher and IL-8 levels were lower in CABP when compared to pyelonephritis or urosepsis.
Conclusions
From the novel potential biomarkers, only PCT demonstrated superiority over the routine parameters in the differentiation of bacterial from viral infections. However, some of the novel parameters should be further evaluated in larger and better characterized cohorts of patients in order to find their clinical applications.
Similar content being viewed by others
Avoid common mistakes on your manuscript.
Purpose
Timely knowledge of the bacterial or viral etiology of infection is necessary for appropriate treatment, including empirical antibiotic therapy. Because the clinical symptoms of severe viral and bacterial infections are often similar, clinicians need reliable diagnostic biomarkers in order to make treatment decisions. Currently, C-reactive protein (CRP), white blood cell (WBC) counts, and neutrophil counts are the most frequently used biomarkers in daily clinical practice [1]. CRP is considered to be the most sensitive biomarker of bacterial infection in both outpatient and inpatient settings [2]. However, high CRP levels, increased WBC counts, or raised neutrophil numbers cannot always differentiate between bacterial, fungal, and severe viral infections [3].
Because of these well-known limitations, other serum biomarkers of bacterial infection, including the serum levels of procalcitonin (PCT), interleukin (IL)-6, and IL-8, have been recommended for use in parallel with old biomarkers [4–6]. Moreover, many other potential biomarkers have been demonstrated in different models of experimental infection and in human bacterial sepsis, including IL-1β, IL-12, tumor necrosis factor α (TNF-α), interferon (IFN)-γ, cortisol, heparin-binding protein (HBP), soluble CD14 (sCD14), and expression markers on the surface of circulating monocytes, including CD14, HLA-DR, toll-like receptor (TLR)2, and TLR4 [7–10]. In addition, some of the above-mentioned biomarkers were also evaluated for the early differentiation of bacterial etiology and focus of the infection [11, 12].
Therefore, the aim of our study was to evaluate these novel potential biomarkers, which were simultaneously analyzed along with routine biomarkers in order to compare their sensitivity and specificity for the differentiation between viral and bacterial infections. Furthermore, the biomarkers were also tested based on the focus of the bacterial infection.
Patients and methods
Patients
This prospective study was conducted after obtaining approval from the Ethics Committee of the University Hospital Bulovka (IRB00002721—Fakultní nemocnice Na Bulovce IRB #1—Biomedical) from April 2007 to September 2009. Adult patients (18–80 years old) presenting fever (axillary temperature ≥38°C) and a clinical diagnosis of infection (see below) were eligible for inclusion in this study if they were admitted to the standard wards of the Department of Infectious Diseases. Primary exclusion criteria consisted of antibiotic therapy prior to hospitalization, transfer from another institution, autoimmune diseases, corticosteroid treatment, malignancy, and HIV infection. All patients gave written informed consent prior to their inclusion in the study, and paired samples of whole peripheral blood and serum were obtained upon the admission to the study.
The diagnosis of bacterial infection was made clinically based on the findings of focal infection. Thus, bacterial pneumonia was confirmed by X-ray showing lobar infiltrate; urosepsis was confirmed with the detection of pathogenic bacteria in the blood, together with signs of urinary tract infection and pyelonephritis, with increased number of WBC count in the urine, ultrasonography findings, and/or elevated CRP; erysipelas and cellulitis was confirmed by characteristic skin signs (i.e., erythematous lesions that are clearly demarcated from the normal skin); invasive meningococcal disease (IMD) was confirmed with petechial rash, fever, and detection of the etiologic agent; toxic shock syndrome and sepsis were confirmed based on the accepted clinical criteria [13–15].
The particular bacterial etiology of the illness was confirmed by cultivation of the pathogenic bacteria from a sterile body fluid (i.e., blood and urine), detection of pneumococcal antigen in urine, detection of bacterial DNA in blood or cerebrospinal fluid (CSF), and serology. Furthermore, all of the patients from this cohort were treated with antibiotics, and a significant decrease in inflammatory markers and clinical improvement were documented. The demographic and clinical data of the 54 enrolled patients with bacterial infection are presented in Table 1. Bacterial etiology was laboratory confirmed in 29 patients, which represented 53.9% of the cases enrolled in this cohort. In these patients, the following etiological agents were detected by cultivation: Escherichia coli 16 times (urine seven times, urine and blood eight times, and blood once), Streptococcus pneumoniae four times, Haemophilus parainfluenzae once, and Staphylococcus hominis once (all detected in the blood only). Pneumococcal urinary antigen assay was positive in two patients (in both cases, S. pneumoniae was also detected in the blood), and polymerase chain reaction (PCR) detected the DNA of Neisseria meningitidis in the blood or CSF from two patients. In addition, a significant rise in antibodies against Chlamydophila pneumoniae indicated an acute infection in three patients, and antibodies against Legionella pneumophila indicated acute infection in one patient.
For comparison, 27 patients with common, acute viral infections that included tick-borne encephalitis (TBE), enteroviral meningitis, viral hepatitis A (VH A), varicella, and parvovirosis were enrolled. In these patients, characteristic clinical and laboratory findings were present (e.g., meningeal irritation and lymphocytic pleocytosis in CSF in TBE or enteroviral meningitis, jaundice, and elevated liver function test in VH A or typical skin findings of clear vesicles on the head and trunk in varicella). The clinical diagnosis was subsequently confirmed with serology, demonstrating specific IgM antibodies. In addition, the etiological diagnosis of enteroviral meningitis was made based on the detection of the viral RNA in the inflammatory CSF. Furthermore, CRP serum levels in this cohort were either within the normal range or mildly elevated, and the patients’ clinical conditions improved without antibiotic treatment. The demographic and clinical characteristics of the 27 patients with viral infection are shown in Table 2.
For the assessment of the influence of the focus of bacterial infection on selected biomarkers, the data of 21 patients with community-acquired bacterial pneumonia (CABP) were compared with the data obtained from 21 cases with pyelonephritis or urosepsis. The clinical and laboratory data of these patients are shown in Table 3.
WBC and differential blood counts
WBC and differential blood counts were determined using a Coulter STKS clinical analyzer (Coulter Electronics Inc., Miami, FL, USA).
Serum levels of soluble mediators
Serum concentrations of CRP were measured on an AU 2700 analyzer (Olympus) using immunoturbidimetry (CRP Latex™, Olympus) with a normal range of 0–8 mg/l. PCT levels were obtained using the enzyme-linked fluorescent assay (ELFA) technique. This assay combines a one-step immunoassay sandwich method with a final automatic fluorescent detection by a VIDAS instrument (VIDAS B.R.A.H.M.S. PCT, bioMérieux, Lyon, France). The measurement range of this instrument was set to 0.05–200 ng/ml.
Serum concentrations of interleukin-1β (IL-1β), IL-6, IL-8, IL-10, IL-12, and TNF-α were measured using a CBA kit (BD™ Cytometric Bead Array—Human Inflammatory cytokine kit) and a three-color FACSCalibur™ flow cytometer (all BD Biosciences, San Jose, CA, USA). The detection limit of the methods for the cytokines was 20 pg/ml. Enzyme-linked immunosorbent assays (ELISAs) were used to measure the IFN-γ (BD Pharmingen, CA, USA), sCD14 (R&D, CA, USA), and HBP levels [16]. The analysis of cortisol was performed on an Architect i2000 immunochemistry analyzer (Abbott, Chicago, IL, USA) using the fluorescence polarization immunoassay FPIA (Abbott), with a normal range of 100–536 nmol/l.
Monocyte surface marker expression
Flow cytometric quantitative analysis of TLR2, TLR4, HLA-DR, and CD14 expression was performed on circulating monocytes using the monoclonal antibodies anti-TLR2, anti-TLR4 (eBiosciences, San Diego, CA, USA), anti-CD14, and anti-HLA-DR (BD Biosciences, San Jose, CA, USA), and the analysis was calculated as a relative mean fluorescent intensity.
Statistical analyses
Statistical analyses were performed using SPSS software™ by a certified biomedical statistician. Data are presented as the medians (interquartile range). Levels that were undetectable were assigned a value equal to the lower limit of detection for the assay. The differences in the analyzed parameters between groups were tested by the Mann–Whitney U-test. The analyses consisted of two-tailed tests with an α-level <0.05. Receiver operating characteristic (ROC) curves were drawn for selected variables as a measure of discriminating power between bacterial and viral infections. The ROC curve shows (on the x-axis) a false-positive rate and (on the y-axis) the sensitivity of a test. The areas under the curves (AUCs) were also evaluated. The correlations among the parameters were tested using Spearman correlation tests.
Results
The groups of patients with viral and bacterial infections did not significantly differ in their mean age and the duration of fever; however, the length of the hospital stay was significantly longer (P = 0.027) in the case of bacterial infection. The results of laboratory analyses and parameter differences between the groups of patients with bacterial and viral infections, including the AUC values, are presented in Table 4. The highest sensitivity and specificity for the diagnosis of bacterial infection demonstrated increased serum levels of PCT and neutrophil blood counts, reduced numbers of circulating lymphocytes, elevated serum concentrations of IL-6, HBP, Cort, and sCD14, as well as increased CD14 expression on blood monocytes; the ROC curves of these markers are presented in Fig. 1. A high sensitivity and specificity for the discrimination of bacterial infection was also found for CD14 expression and IL-8 levels. In addition, serum concentrations of IFN-γ, TNF-α, IL-1β, IL-10, and IL-12 and the monocyte expression of HLA-DR, TLR2, and TLR4 revealed the lack of a difference between the patients with bacterial infections versus the patients with viral infections.
Regarding the focus of the bacterial infection, the serum concentration of IFN-γ was significantly higher in patients with CABP in comparison to patients with pyelonephritis or urosepsis. Similarly, Cort was significantly higher in CABP cases when compared to pyelonephritis or urosepsis. Conversely, IL-8 was higher in patients with pyelonephritis and urosepsis in comparison to CABP cases. The data obtained from both groups of patients and their statistical comparisons are presented in Table 3.
Also, correlations among the parameters were evaluated in the cohorts with bacterial and viral infections. The strongest (r > 0.6) and most significant correlations (P < 0.001) in the cohort with bacterial infection were the following: PCT with IL-6 and IL-8 (r = 0.724; r = 0.633, respectively), IL-6 with IL-8 (r = 0.833), and TLR4 expression with CD14 and TLR2 (r = 0.688 in both cases). The only correlation observed in the cohort with viral infection was between TLR2 and TLR4 expression (r = 0.851, P < 0.001).
Discussion
Several biomarkers were tested with the aim of identifying optimal parameters for diagnostic use in routine clinical practice. We tested the biomarkers in febrile patients that were hospitalized in the Department of Infectious Diseases for a severe course of bacterial or viral infection. These biomarkers included soluble serum molecules and surface markers expressed on circulating monocytes.
PCT was found to have the highest sensitivity and specificity for bacterial infections in this study. This result supports findings from previous studies, where elevated PCT values indicated systemic bacterial infections [17, 18]. It has also been shown that PCT is produced shortly after stimulation, within 6 h, in comparison to 24 h for CRP. Thus, PCT may provide a helpful tool for the rapid detection of bacterial infections, which has already been demonstrated in children with IMD examined for fever in emergency care departments [19]. Furthermore, the PCT-based diagnostic algorithm supports the cautious use of antibiotics and has a favorable effect on clinical outcomes [20].
The second most reliable soluble biomarker that can discriminate viral and bacterial infections evaluated in our study was HBP. Elevated serum levels of HBP, which is stored in leukocytes and rapidly released after their stimulation, were already demonstrated in IMD, leptospirosis, and tropical malaria, as well as in severe sepsis and septic shock [8, 21]. However, the difference of HBP serum levels in association with the etiology of infection is a novel observation, which may indicate a role of this protein during less severe infectious processes.
From the other soluble biomarkers, we observed a good sensitivity and specificity for IL-6, Cort, and sCD14. IL-6 is a proinflammatory cytokine produced by monocytes and macrophages activated during bacterial infection, although it exerts its function more broadly due to its anti-inflammatory properties by activating inhibitory mechanisms of the acute-phase response. It has been documented that IL-6 is elevated in blood earlier than CRP during the course of bacterial infection [22]. Noor et al. [23] compared the usefulness of IL-6 with CRP in neonatal sepsis and discovered that IL-6 was the earliest marker of neonatal infection. However, we did not observe IL-6 in more than one-third of our patients with bacterial infection (data not shown), suggesting the limitations of IL-6 in less severe bacterial infections. The finding of higher Cort concentrations in bacterial infections in comparison to viral infections is in accordance with our earlier observations in patients with meningitis; cortisol levels in CSF were significantly higher in patients with bacterial meningitis in comparison to patients with viral meningitis. It is worth noting that cortisol levels of 46.1 nmol/l in CSF had 82% sensitivity and 100% specificity for the diagnosis of bacterial meningitis [24]. The importance of S-Cort observed in this study for the distinction between bacterial and viral infections has not yet been described.
It is interesting that both the CD14 expression on circulating monocytes and the serum level of sCD14 proved to be good biomarkers for the differentiation between bacterial and viral infections. Similar to membrane-bound CD14 (mCD14), sCD14 plays a crucial role in host defense against Gram-negative and Gram-positive pathogens, as sCD14 functions as a pattern recognition receptor of the innate immune response [25]. High levels of both mCD14 and sCD14 have been associated with a poor outcome of sepsis. Aalto et al. [26] measured mCD14 and sCD14 in patients with severe community-acquired infections and found a significant positive correlation between S-CRP and sCD14 levels, providing evidence that sCD14 may serve as an acute-phase reactant.
Regarding the differences in the observed results based on the focus of the infection, the highest serum levels of IFN-γ and Cort in CABP in comparison to pyelonephritis and urosepsis might be of interest. However, it is worth noting that the highest serum IFN-γ concentrations were observed in patients with pneumonia due to C. pneumoniae or CABP of unknown origin (data not shown). The high IFN-γ serum levels in CABP of chlamydial etiology may indicate an activation of intracellular killing mechanisms that are important for the elimination of the bacteria [27]. Next, the patients with the highest Cort levels had bacteremic pneumococcal pneumonia, reflecting a more severe course of infection compared to non-bacteremic pneumonia. In addition, higher IL-8 levels observed in pyelonephritis and urosepsis in comparison to CABP are suggestive of the Gram-negative etiology of infection and stimulatory effects of endotoxin [28].
It is not surprising that we observed a high discriminating power (AUC 0.852) of an increased number of neutrophils during bacterial infection in our study. This finding only stresses the well-known fact that the number of circulating neutrophils is a much better marker of bacterial infection than the number of WBCs. However, the observed decreased number of circulating lymphocytes predicting the bacterial origin of infection (AUC 0.841) is interesting because circulating lymphocytes are not frequently used by clinicians. The reason for the poorly estimated value of low lymphocyte numbers in bacterial infections could be that most authors describe lymphocytopenia in association with severe sepsis and septic shock [29].
Though TLRs are rapidly responding pattern-recognition receptors, we did not observe a significant modulation of TLR2 and TLR4 expression by distinct infections; therefore, the expression levels of these receptors do not seem to be useful for distinguishing between bacterial and viral infections. The same trend holds true for mCD14, which is modulated by experimental endotoxemia, and HLA-DR, which is altered in patients with a poor outcome of severe sepsis and septic shock [30]. Similarly, the early biomarkers that are rapidly produced after the stimulation of monocytes (i.e., IL-1β, IL-12, TNF-α, and IFN-γ) did not differ between viral and bacterial infections, which could be explained by the fact that the above-mentioned cytokines have rapid kinetics and their production is down-regulated shortly after stimulation [31].
We are aware of certain limitations to our study. First, the final etiological diagnosis was based not only on the results of microbiology methods, but also on the clinical decision supported by the findings of focal infection, elevated CRP serum levels (in the case of pyelonephritis), the clinical course, and the effects of empirical antibiotic therapy. Although this study design respects common clinical practices, it might lead to a bias. Thus, the clinical diagnosis was finally reviewed by an expert (i.e., an infectious disease consultant) who was not involved in the patients’ care. Second, we could not reliably compare CRP with the other biomarkers because this parameter was used for the diagnosis of pyelonephritis. Third, because we had to use quite stringent enrollment criteria in order to eliminate factors that could influence selected biomarkers and because the cohorts of patients were relatively small, the results have limited applicability. Therefore, further clinical studies with larger cohorts of patients should be performed to confirm the reported findings.
Conclusion
Our results strongly support the use of the procalcitonin (PCT) serum level as a routine biomarker of bacterial infection. Furthermore, some of the novel potential biomarkers (i.e., heparin-binding protein [HBP], interleukin-6 [IL-6], cortisol [Cort], interferon [IFN]-γ, and IL-8) demonstrated interesting differences based on the etiology and localization of infection, suggesting potential for their future clinical use.
Abbreviations
- S-PCT:
-
Serum level of procalcitonin
- S-HBP:
-
Serum level of heparin-binding protein
- S-Cort:
-
Serum level of cortisol
References
Adams NG. Diagnostic use of C-reactive protein in bacteraemic emergency department patients. Emerg Med Australas. 2005;17:371–5.
Klein JO. Management of the febrile child without a focus of infection in the era of universal pneumococcal immunization. Pediatr Infect Dis J. 2002;21:584–8. Discussion 613–4.
Ho KM, Lipman J. An update on C-reactive protein for intensivists. Anaesth Intensive Care. 2009;37:234–41.
Assicot M, Gendrel D, Carsin H, Raymond J, Guilbaud J, Bohuon C. High serum procalcitonin concentrations in patients with sepsis and infection. Lancet. 1993;34:515–8.
Huang SY, Tang RB, Chen SJ, Chung RL. Serum interleukin-6 level as a diagnostic test in children with sepsis. J Chin Med Assoc. 2003;66:523–7.
Russell JA. Management of sepsis. N Engl J Med. 2006;355:1669–713. Erratum in: N Engl J Med. 2006;355:2267.
Kim D, Reilly A, Lawrence DA. Relationships between IFN gamma, IL-6, corticosterone, and Listeria monocytogenes pathogenesis in BALB/c mice. Cell Immunol. 2001;207:13–8.
Linder A, Christensson B, Herwald H, Björck L, Akesson P. Heparin-binding protein: an early marker of circulatory failure in sepsis. Clin Infect Dis. 2009;49:1044–50.
Cheadle WG. The human leukocyte antigens and their relationship to infection. Am J Surg. 1993;165:75S–81S.
Härter L, Mica L, Stocker R, Trentz O, Keel M. Increased expression of toll-like receptor-2 and -4 on leukocytes from patients with sepsis. Shock. 2004;22:403–9.
Kragsbjerg P, Jones I, Vikerfors T, Holmberg H. Diagnostic value of blood cytokine concentrations in acute pneumonia. Thorax. 1995;50:1253–7.
Nanda N, Juthani-Mehta M. Novel biomarkers for the diagnosis of urinary tract infection—a systematic review. Biomark Insights. 2009;4:111–21.
Huang DT, Huang FY, Tsai TC, Tsai JD, Chiu NC, Lin CC. Clinical differentiation of acute pyelonephritis from lower urinary tract infection in children. J Microbiol Immunol Infect. 2007;40:513–7.
Costa Orvay JA, Caritg Bosch J, Morillo Palomo A, Noguera Julián T, Esteban Torne E, Palomeque Rico A. Toxic shock syndrome: experience in a pediatric intensive care unit. An Pediatr (Barc). 2007;66:566–72.
Bone RC, Balk RA, Cerra FB, Dellinger RP, Fein AM, Knaus WA, Schein RM, Sibbald WJ. Definitions for sepis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine. Chest. 1992;101:1644–55.
Tapper H, Karlsson A, Mörgelin M, Flodgaard H, Herwald H. Secretion of heparin-binding protein from human neutrophils is determined by its localization in azurophilic granules and secretory vesicles. Blood. 2002;99:1785–93.
Hochreiter M, Köhler T, Schweiger AM, Keck FS, Bein B, von Spiegel T, Schroeder S. Procalcitonin to guide duration of antibiotic therapy in intensive care patients: a randomized prospective controlled trial. Crit Care. 2009;13:R83.
Stankovic Stojanovic K, Steichen O, Lionnet F, Bachmeyer C, Lecomte I, Avellino V, Grateau G, Girot R, Lefevre G. Is procalcitonin a marker of invasive bacterial infection in acute sickle-cell vaso-occlusive crisis? Infection. 2011;39:41–5.
Mills GD, Lala HM, Oehley MR, Craig AB, Barratt K, Hood D, Thornley CN, Nesdale A, Manikkam NE, Reeve P. Elevated procalcitonin as a diagnostic marker in meningococcal disease. Eur J Clin Microbiol Infect Dis. 2006;25:501–9.
Müller B, Schuetz P, Trampuz A. Circulating biomarkers as surrogates for bloodstream infections. Int J Antimicrob Agents. 2007;30:S16–23.
Beran O, Herwald H, Dzupová O, Chalupa P, Holub M. Heparin-binding protein as a biomarker of circulatory failure during severe infections: a report of three cases. Scand J Infect Dis. 2010;42:634–6.
Lannergård A, Viberg A, Cars O, Karlsson MO, Sandström M, Larsson A. The time course of body temperature, serum amyloid A protein, C-reactive protein and interleukin-6 in patients with bacterial infection during the initial 3 days of antibiotic therapy. Scand J Infect Dis. 2009;41:663–71.
Noor MK, Shahidullah M, Mutanabbi M, Barua C, Mannan MA, Afroza S. Comparison between CRP and IL-6 as early markers of neonatal sepsis. Mymensingh Med J. 2008;17:S72–6.
Holub M, Beran O, Dzupová O, Hnyková J, Lacinová Z, Príhodová J, Procházka B, Helcl M. Cortisol levels in cerebrospinal fluid correlate with severity and bacterial origin of meningitis. Crit Care. 2007;11:R41.
de Aguiar BB, Girardi I, Paskulin DD, de Franca E, Dornelles C, Dias FS, Bonorino C, Alho CS. CD14 expression in the first 24 h of sepsis: effect of -260C > T CD14 SNP. Immunol Incest. 2008;37:752–69.
Aalto H, Takala A, Kautiainen H, Siitonen S, Repo H. Monocyte CD14 and soluble CD14 in predicting mortality of patients with severe community acquired infection. Scand J Infect Dis. 2007;39:596–603.
Rothfuchs AG, Kreuger MR, Wigzell H, Rottenberg ME. Macrophages, CD4+ or CD8+ cells are each sufficient for protection against Chlamydia pneumoniae infection through their ability to secrete IFN-gamma. J Immunol. 2004;172:2407–15.
O’Brien JM Jr, Abraham E. Human models of endotoxemia and recombinant human activated protein C. Crit Care Med. 2004;32:S202–8.
Unsinger J, Kazama H, McDonough JS, Hotchkiss RS, Ferguson TA. Differential lymphopenia-induced homeostatic proliferation for CD4(+) and CD8(+) T cells following septic injury. J Leukoc Biol. 2009;85:382–90.
Lukaszewicz AC, Grienay M, Resche-Rigon M, Pirracchio R, Faivre V, Boval B, Payen D. Monocytic HLA-DR expression in intensive care patients: interest for prognosis and secondary infection prediction. Crit Care Med. 2009;37:2746–52.
Jansen PM, van der Pouw Kraan TC, de Jong IW, van Mierlo G, Wijdenes J, Chang AA, Aarden LA, Taylor FB Jr, Hack CE. Release of interleukin-12 in experimental Escherichia coli septic shock in baboons: relation to plasma levels of interleukin-10 and interferon-gamma. Blood. 1996;87:5144–51.
Acknowledgments
The authors would like to thank B. Horová, MD, and B. Sýkorová, MD, for the examinations of PCT and sCD14, and Z. Manďákova, MD, H. Rozsypal, MD, and D. Jilich, MD, for their help with the patient enrollment (all from University Hospital Bulovka, Prague, Czech Republic). The study was supported by the Grants IGA NR/9316-3 and NT/11390-5 from the Ministry of Health and by the Grant MSM 0021620806 from the Ministry of Education, Youth and Sports, Czech Republic.
Conflict of interest
Hansa Medical (Lund, Sweden) has filed patent applications, on HBP as a diagnostic target, and H.H. is listed as one of the inventors. The patent application is pending.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Chalupa, P., Beran, O., Herwald, H. et al. Evaluation of potential biomarkers for the discrimination of bacterial and viral infections. Infection 39, 411–417 (2011). https://doi.org/10.1007/s15010-011-0126-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s15010-011-0126-4